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To understand the adaptations of costimulatory molecules through mammalian evolution, Forni et al.
(Forni et al., 2013) studied evolutionary selection in key costimulatory genes. Their results, presented in
this issue of Immunity, suggest that the risk of autoimmmunity is balanced against efficacy of the anti-path-
ogen immune response.To better understand the consequences
and causes of genetic selection in mole-
cules that regulate T cell responses,
Forni et al. (2013) studied the evolution
of key T cell regulatory molecules across
the 175 million years of mammalian
diversification. They examined the
APC:Tcell ligand-receptor pairs of CD80–
CD86:CD28-CTLA-4, PD-L1-PD-L2:PD-
1, ICOSLG:ICOS, Galectin-9:TIM-3,
FASLG:FAS, and CD40:CD40LG. These
regulate the strength, speed, and duration
of immune responses andwere chosen on
the basis of their importance, well-charac-
terized functions, and known structures.
Selective pressure on the genes encod-
ing the molecules that regulate immune
responses has resulted in the positive
selection of alleles that provide a survival
advantage. Forni et al. compared the
coding sequences of T cell regulatory
molecules from 39 mammalian species
and determined where selective pressure
has changed the molecules. They did this
by calculating the dN/dS ratio of non-
synonymous (dN, changes amino acid)
to synonymous (dS, doesn’t change
amino acid) changes at codons across
the length of the proteins. They identified
a small number of amino acids in nine
of the 15 T cell regulatory molecules
(CD80, CD86, CD28, PD-L1, PD-L2,
TIM-3, Galectin-9, FAS, and CD40) for
which dN/dS was significantly >1, indi-cating that the amino acid was under pos-
itive selection and thus that it provided a
selective advantage to that species.
To determine possible reasons for
selection in the coding regions of these
genes, Forni et al. mapped the positively
selected amino acids onto the crystal
structures of the proteins, represented
schematically in Figure 1. They showed
‘‘hot spots’’ of positive selection, including
the CD28 transmembrane domain, the
CD80 IgV-like domain (IgV), the CD86
IgC-like (IgC) domain, the stalk and trans-
membrane domains, the PD-L1 and PD-
L2 stalk domains, the TIM-3 IgV domain,
and a broad distribution across the
FAS extracellular and intracellular death
domains. They found that the CD80 IgV
domain has three positively selected sites
in the CTLA-4 binding region and two in
the region where two CD80 IgV domains
interact in a back-to-back fashion to
form a noncovalent homodimer.
Surprisingly, many positively selected
sites of variation in CD86 are in the IgC
domain, which does not interact with
any known ligand. Previous work has
shown that Ig fusion proteins containing
the CD86 IgV domain alone were 100-
fold more potent at stimulating T cell
activation than those containing both IgV
and IgC domains (Rennert et al., 1997).
These results suggest an unappreciated
role of the CD86 IgC domain in attenu-ating activity of the IgV domain or interac-
tion of the IgC with another receptor. The
human KSHV (Karposi’s sarcoma-associ-
ated herpesvirus) encodes a protein,
MIR2, that interacts with the stalk and
transmembrane region of human CD86
and leads to the ubiquitination and degra-
dation of CD86.Molecular modeling of the
two hydrophobic amino acids positively
selected in primate CD86 transmembrane
domains shows that they interact with the
MIR2 transmembrane domain, whereas
the less hydrophobic amino acids present
in nonprimate genomes do not support
the interaction. These stronger interac-
tions in primates might modulate activity
of the viral ubiquitinase and represent
host adaption to viral pathogenesis.
One of the positively selected sites in
the PD-L1 IgV domain is adjacent to the
PD-1 binding surface. However, most of
the selected sites in both PD-L1 and
PD-L2 are in the stalk domain. The bind-
ing of PD-L1 and PD-L2 to PD-1 occurs
on the side of the IgV domain and requires
a somewhat horizontal positioning of the
proteins (Freeman, 2008). Positively
selected sites in the stalk might modulate
the capacity of the PD-1 ligand to bend
and assume an optimal positioning for
binding to PD-1 on another cell or the
capacity to form cis interactions with
PD-1 or CD80 on the same cell surface.
Alternatively, selected sites in the stalk8, June 27, 2013 ª2013 Elsevier Inc. 1083
Figure 1. T Cell Regulatory Molecules Are Illustrated as Ligand-Receptor Pairs
Sites of positive selection in the proteins are represented by red lines in the domain (one line per variant identified in Forni, et al.), and positively selected non-
coding SNPs are represented as red dots (one dot for each autoimmune-disease-associated SNP that is correlated with pathogen diversity). Known receptor-
ligand binding geometries and stoichiometries, such as the tight angle between CD28 IgV domains, which sterically prevents binding with two CD80 or CD86
molecules, and the wide angle between IgV domains in CTLA-4, which allows binding of CD80 and/or CD86 on each side, are shown.
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lytic cleavage and shedding of immunoin-
hibitory soluble PD-L1 or PD-L2 (Frigola
et al., 2011).
Three positively selected sites in the
cytoplasmic domain of FAS are involved
in binding to FADD, an intracellular
adaptor that transduces the apoptotic
signal and so might affect the strength of
the death signal. Similarly, the sites in the
FAS extracellular domain are clustered in
the area of FASLG binding. One positively
selected site in the CD40 extracellular
domain is involved in CD40LG binding,
and sites in the CD40 cytoplasmic domain
are involved in binding of the signal-
transduction molecules Ku, JAK3, and
TRAF6. The positively selected sites in
TIM-3 are all in the IgV domain and include
two hydrophobic amino acids that form
one side of the phosphatidylserine (PS)
binding pocket and are known to regulate
affinity for PS (DeKruyff et al., 2010). This
illustrates how these positively selected
sites might lead to different strengths
and varied importance of the T cell regu-
latory molecules in different species.
These results show the insights that
can be derived from analysis of positively
selected sites and allow the generation
of new hypotheses. In particular, the find-
ings of Forni et al. suggest experiments to
better understand the function of the1084 Immunity 38, June 27, 2013 ª2013 ElseCD86 IgC domain and the PD-L1 and
PD-L2 stalk domains. Overall, the com-
parative analyses of these genes across
species identifies ‘‘hot spots’’ of variation
at regions of interaction between recep-
tors and ligands and between pathogens
and host receptors, and they also suggest
unidentified molecular interactions.
The authors next investigated whether
natural selection has affected genetic
diversity of T cell regulatory genes in
human populations across the 0.25
million years of human diversification.
They used the 1000 Genomes data (Abe-
casis et al., 2012) (lightly sequenced ge-
nomes of about 1,200 individuals from
13 worldwide populations) and single-
nucleotide polymorphism (SNP) data
from the Human Genome Diversity Panel
to calculate measures of genetic diversity
and differentiation and haplotype homo-
zygosity among continental groups. Six
genes (those encoding CD80, PD-L1,
TIM-3, CD40LG, FAS, and PD-1) satisfied
the criteria of reaching significance in at
least two of these tests.
Despite evidence for positive selection
in T cell regulatory-molecule coding se-
quences between species, the analysis
of human genomes revealed evidence for
selection of variation only in noncoding
genomic sequences. These might modu-
late expression of the T cell regulatoryvier Inc.genes, e.g., the exon that encodes the
IgV domain of TIM-3 sequences demon-
strates marked variation between species
but no such variation within the human
species. Rather, the positively selected
noncoding sites in TIM-3 appear to be reg-
ulatory elements, such as a variant in the 30
untranslated regionofTIM-3at apredicted
binding site formicroRNA (miR)-379. Simi-
larly, a functional polymorphism in the pro-
moter region of FAS, rs1800682, regulates
binding of the STAT1 transcription factor
and interferon-g (IFN-g) responses.
The geographic distributions of
selected variants were compared to the
selective pressure exerted in these
geographic regions by four classes of
pathogen: viruses, bacteria, protozoa,
and helminthes. The methods used for
estimating pathogen diversity in geo-
graphic regions depend somewhat on
current diversity and so could be criticized
as not being sufficiently accurate across
time. Forni et al. found that the PD-L1,
FASLG, and CD40LG variants that are
likely to regulate gene expression are
geographically restricted in a manner
correlated with pathogen diversity.
Although gene transfer from Neander-
thals to humans populations remains con-
troversial (Sankararaman et al., 2012),
Forni et al. present evidence that a PD-1
variant represents gene flow from humans
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that are strongly selected for and main-
tained at a high frequency of homozy-
gosity in Asian populations is similar to
Neanderthal but not Denisovan genomes.
This is most consistent with the idea that
interbreeding led to introduction of these
human alleles into the Neanderthal
genome and with selection due to
shared local pressures, such as com-
mon pathogens, in human and Nean-
derthal populations in Asia. It appears
that a little humanity was good for the
Neanderthal.
Forni et al. found that for seven of
13 disease-associated SNPs in genes
encoding T cell regulatory molecules, the
frequency of the risk allele increased
with the diversity of at least one pathogen
group. Six of these seven disease-associ-
ated SNPs were autoimmune-disease-
associated variants that correlated
positively with pathogen diversity. This is
consistent with autoimmune-disease risk
alleles’ conferring protection against
pathogens and selection of these alleles
as adaptation to pathogen-driven selec-
tive pressures. The one disease-associ-
ated SNP in which the risk allele was
negatively associated with pathogen
load was a FAS variant associated with
IgA deficiency. This negative correlation
would be expected as a result of the
increased risk of life-threatening infec-
tions in individuals with IgA deficiency.
Genome-wide association studies
(GWASs) have identified several hundredloci associated with various diseases.
When GWASs first identified noncoding
SNPs as associated with disease, most
biologists expected that these were con-
venient followers of some coding variant
that was the true disease-associated
change. This has turned out rarely to be
the case, and identifying the causal muta-
tion in a locus has been difficult. The
coding variation in humans is surprisingly
limited, and only an estimated 0.5% of
nonsynonymous amino acid changes in
the past 250,000 years have been posi-
tively selected. This suggests a startlingly
low number of nonsynonymous adaptive
mutations in the human genome; that
number is estimated to be less than 340
(Grossman et al., 2013; Hernandez et al.,
2011). Grossman et al. estimated only 38
causal nonsynonymous amino acid
changes among 412 GWAS-selected
loci (Grossman et al., 2013). These results
and those of Forni et al. suggest that the
great majority of selected mutations
occur in regulatory elements that control
gene expression, rather than in coding re-
gions (Grossman et al., 2013; Hernandez
et al., 2011; Jostins et al., 2012). Forni
et al. demonstrate that allelic variation in
the T cell regulatory genes is associated
with selective pressures from pathogens,
and this pressure for the immune
response to be faster or stronger has
selected for autoimmune-disease-asso-
ciated alleles in these genes. Thus, immu-
nity can be a choice between a rock and a
hard place.Immunity 3REFERENCES
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Unwarranted NLRP3 activation causes inflammatory disease. Its activation must therefore be specifically
licensed. In this issue of Immunity, Munoz-Planillo et al. (2013) reveal K+ efflux as the sole common denom-
inator of an array of unrelated stimuli engaging this inflammasome.The NLRP3 inflammasome was originally
identified through its association with
three hereditary autoinflammatory syn-dromes that are characterized by urticar-
ial skin rashes and prolonged episodes
of fever. An important subset of patientssuffering from the autosomal-dominant
periodic fever syndromes—familial cold
autoinflammatory syndrome (FCAS),8, June 27, 2013 ª2013 Elsevier Inc. 1085
